—

TG Therapeutics Inc (TGTX) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 56 out of 100 (momentum 96 · quality 68 · valuation 22), as of 2026-11-11.
  • Signal: Uptrend stack intact — Trades +14.4% vs the 50-day and +43.2% vs the 200-day average, 5.5% below the 52-week high and +140.1% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: TG Therapeutics Inc trades 14.4% above its 50-day and 43.2% above its 200-day moving average. (as of 2026-11-10)

TG Therapeutics is a commercial-stage biopharmaceutical company that develops treatments for diseases driven by B-cells, a type of immune cell. Its approved product, an antibody therapy for relapsing forms of multiple sclerosis, is sold in the United States and other markets.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the TGTX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +14.4% vs the 50-day and +43.2% vs the 200-day average, 5.5% below the 52-week high and +140.1% off the 52-week low. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on TGTX?

Uptrend stack intact — Trades +14.4% vs the 50-day and +43.2% vs the 200-day average, 5.5% below the 52-week high and +140.1% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is TGTX above its 50-day and 200-day moving averages?

As of 2026-11-10, TG Therapeutics Inc trades +14.4% above its 50-day and +43.2% above its 200-day average, with the 20-day +11.9% away.

How far is TGTX from its 52-week high?

5.5% below the 52-week high and 140.1% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.